With Valentine’s Day approaching, new data from female health specialists Forth reveals why many women may feel emotionally close to their partner but physically disconnected from sex.
According to the data from Forth, testosterone levels in women decline by more than 51% with age, significantly impacting sexual desire, arousal and physical pleasure. Testosterone, often incorrectly viewed as a male hormone, plays a crucial role in women’s libido, sexual sensation and ability to reach orgasm.
Forth’s research shows that women aged 18 – 29 have an average testosterone level of 1.24 nmol/L, compared to just 0.6 nmol/L in women over 60. Levels drop even more sharply after menopause, with a 31% reduction in post-menopausal women, helping explain why sexual desire often changes dramatically later in life.
This decline in libido after the menopause is often regarded as normal, but it can have a profound impact on a woman’s quality of life and put pressure on relationships. When these changes are persistent and pervasive, it could be a sign of Female Sexual Dysfunction (FSD).
FSD is a condition affecting desire, arousal, orgasm and comfort during sex. FSD can cause significant emotional distress, impacting intimacy, confidence and relationships. In fact, 7 in 10 women have blamed menopause for the breakdown of their relationship, highlighting the real-world consequences of unmet sexual health needs.
Although not the whole picture, testosterone can play a significant role in helping to improve women’s sexual experiences. The research comes as the news that the Medicines and Healthcare products Regulatory Agency (MHRA), has approved the first-ever testosterone cream for menopausal women in the UK[1]. Already licensed in Australia, New Zealand and South Africa, the UK will become only the fourth country to approve it with women being able to request it from their GP. This marks a pinnacle moment in the support available for women in mid-life.
Women are not being asked the right questions
While the increased availability of testosterone for women is a step forward, what these findings show is that despite this latest development, conversations about women’s sexual health and hormones still remain largely absent from routine healthcare.
Forth’s research highlights a widespread lack of understanding around testosterone and its role in female health, leaving many women believing that a loss of desire is simply something they have to accept.
Dr Thom Phillips, Chief Medical Officer, Forth, says: “Men are routinely asked about erectile dysfunction as part of conversations about their general health and wellbeing. Yet discussions about sexual desire and function are often missing from consultations with women, even though the underlying physical and emotional factors are just as common and equally important.
“We often use the term ‘libido’ to cover everything, but sexual desire and sexual satisfaction are two distinct things. A woman may want intimacy but find the physical experience uncomfortable or unfulfilling. Issues like vaginal dryness or pain during sex can quickly create a vicious cycle that affects both desire and pleasure.
“While testosterone decline is a major driver, libido is also influenced by stress, sleep, energy levels, mental health, body image and relationship dynamics. A low sex drive isn’t automatically a problem, but if it’s causing distress or affecting daily life, it deserves attention and support.”
Knowledge is powerFor women who sense that something has changed but don’t know where to start, the team at Forth use a scientifically validated Female Sexual Function Index (FSFI) questionnaire[2] to help try and identify where the issues around intimacy lie. The tool provides women with a score that can be taken to their GP to help initiate an informed, productive conversation about sexual health.
Dr Thom Phillips, says: “Many women feel embarrassed raising these issues, and even when they do, UK GPs often lack specialist training in sexual medicine. This lack of awareness, combined with limited NHS resources for psychosexual therapy, means women are often left thinking there isn’t much that can be done.
“Completing an FSFI questionnaire can serve as a tool to empower women with more knowledge and confidence when speaking to their GP. It acts as a clear barometer that can help guide further investigation and treatment.”
[1] https://mhraproducts4853.blob.core.windows.net/docs/6f5c86bfb5b17ab2f9f219e3ff8d0188a500e085#:~:text=Why%20was%20AndroFeme%20approved?,can%20be%20approved%20for%20use.
[2] https://www.forthwithlife.co.uk/blog/female-sexual-dysfunction-fsfi-questionnaire/
